Sign in

    Ray Guo • China International Capital Corporation

    Ray Guo is a Vice President and Equity Analyst at China International Capital Corporation, specializing in equity research with a focus on major Hong Kong and China-listed companies in the consumer and healthcare sectors. He covers leading companies such as HUTCHMED and others in these industries, with his research demonstrating a robust performance track record recognized by institutional investors. Guo began his financial career in the early 2010s, advancing to his current role at CICC after previous analytical positions within the sector. He holds industry certifications relevant to equity analysis and investment banking within Hong Kong and mainland China, reflecting his strong professional credentials.

    Ray Guo's questions to Huize Holding Ltd (HUIZ) leadership

    Ray Guo's questions to Huize Holding Ltd (HUIZ) leadership • Q3 2024

    Question

    Ray Guo from CICC asked about Huize's future plans for the health management industry, particularly regarding potential access to hospital data, and inquired if the company had any First Year Premium (FYP) guidance for 2025.

    Answer

    Co-CFO Kwok Ho Tam responded that Huize has an early-stage Internet health platform and plans to focus on developing customized mid-to-high-end medical products to address market needs from healthcare reforms, with a new product expected in the next two quarters. He stated that it was too early to provide FYP guidance for 2025, which will be shared during the Q4 results call.

    Ask Fintool Equity Research AI